三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
奥雷巴替尼治疗CPCML生存率
奥雷巴替尼治疗CPCML生存率
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:215KB
图片尺寸:1060*671
同报告图片
/
4
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
fCDkuqflk4EgIHwg5LyB5LiaICAgfCDlm73lhoXkuLTluorpmLbmrrUgfAp8LS0tLS0tLXwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCDlpaXpm7flt7Tmm7/lsLwgfCDkuprnm5vljLvoja8gfCDkuIrluIIgICAgICAgICAgfAp8IOaZrue6s+abv+WwvCAgIHwg5q2m55SwICAgICB8IElJSSAgICAgICAgICAgfAp8IFRHUlgtNjc4IHwg5aGU5ZCJ55Ge55Sf54mpIHwgSSAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWMu+iNr+mtlOaWue+8jOilv+WNl+ivgeWIuOaVtOeQhg==
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
所属报告:
亚盛医药-港股公司研究报告-小荷才露尖尖角细胞凋亡赛道大有可为-230507(36页).pdf
打包全文图表
相关数据
中国癌症患者2003-2012年的5年生存率
收藏
行业数据
2026-04-20
原图定位
查看详情
图3.4. 癌症生存率低于OECD平均水平
收藏
竞争格局
2026-04-01
原图定位
查看详情
五年总体生存率一览 选定的儿童癌症:(2000–2022)
收藏
行业数据
2026-02-13
原图定位
查看详情
选择性儿童中枢神经系统肿瘤的发病率和5年总生存率 神经系统肿瘤:2000–2022
收藏
行业数据
2026-02-13
原图定位
查看详情
补充表 1 美国的儿童癌症:按年龄划分的发病率和5年生存率
收藏
行业数据
2026-02-13
原图定位
查看详情
图 W36 全球儿童癌症生存率分布
收藏
行业数据
2026-02-13
原图定位
查看详情
2022年我国胃癌新发和死亡病例及不同期胃癌治疗后五年生存率
PHxiZWdpbl9vZl9ib3h8Pnwg57G75YirICAgICAgICAgICAgICAgICAgICAgfCDmlbDmja4gICAgICAgICAgICAgICAgICB8CnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCDmiJHlm70yMDIy5bm06IOD55mM5paw5Y+R55eF5pWwICAgfCAzNTgsNjcy5L6LICAgICAgICAgICAgIHwKfCDmiJHlm70yMDIy5bm06IOD55mM5paw5Y+R55eF5pWw5o6S5ZCNIHwg56ysNeS9jSAgICAgICAgICAgICAgICAgfAp8IOaIkeWbvTIwMjLlubTog4PnmYzmrbvkuqHnl4XmlbAgICB8IDI2MCwzNzLkvosgICAgICAgICAgICAgfAp8IOaIkeWbvTIwMjLlubTog4PnmYzmrbvkuqHnl4XmlbDmjpLlkI0gfCDnrKwz5L2NICAgICAgICAgICAgICAgICB8Cnwg6L+b5bGV5pyf6IOD55mM5omL5pyv5ZCONeW5tOeUn+WtmOeOhyB8IO+8nDMwJSAgICAgICAgICAgICAgICAgfAp8IOaXqeacn+iDg+eZjOayu+eWl+WQjjXlubTnlJ/lrZjnjocgICB8IO+8njkwJSAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5Zu+54mH5omA56S65pWw5o2u77yI5YW35L2T5p2l5rqQ5pyq5piO56Gu5qCH5rOo77yJPHxlbmRfb2ZfYm94fD4=
收藏
行业数据
2025-12-10
原图定位
查看详情
美国国家癌症中心统计2015-2021年各瘤种五年生存率(%)
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
收藏
行业数据
2025-08-25
原图定位
查看详情
图8奥雷巴替尼临床获益以及耐受性情况
5aW955qE77yM5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOmhueebriB8IOaVsOaNriB8CnwtLS0tLS18LS0tLS0tfAp8IOe7j+a3seW6puayu+eWl+eahENNTC1DUOaCo+iAheaVsOmHjyAoTj02MikgfCA1MiXmgqPogIXml6LlvoDmjqXlj5fiiaU056eNVEtJc+ayu+eWlyB8CnwgMjkl5oKj6ICF5pC65bimVDMxNUnnqoHlj5ggfCA1MCXmgqPogIXml6LlvoDmjqXlj5fkvIrpqazmm7/lsLzmsrvnlpcgfAp8IDI3JeaCo+iAheaXouW+gOaOpeWPl+mYv+aAneWwvOW4g+ayu+eWlyB8IOmVv+acn+ayu+eWl+aVsOaNriB8CnwgNDjlkaggLSBDTUwtQ1DmgqPogIXnmoTmsrvnlpfml7bplb8gfCAzLjLlubQgLSBDTUwtQ1DmgqPogIXnmoTmnIDplb/msrvnlpfml7bplb8gfAp8IOWlpembt+W3tOabv+WwvOiAkOWPl+aAp+iJr+WlvSB8IOacgOW4uOingSAo4omlMTAlKSDnmoTmsrvnlpfmnJ/pl7TkuI3oia/kuovku7YgfAp8IOihgOiCjOmFuOejt+mFuOa/gOmFtuWNh+mrmCB8IDM5JSAoMS0y57qnKSAxMyUgKOKJpTPnuqcpIHwKfCDooYDlsI/mnb/lh4/lsJHnl4cgfCAyOSUgKDEtMue6pykgMTglICjiiaUz57qnKSB8Cnwg5oG25b+DIHwgMjYlICgxLTLnuqcpIDAlICjiiaUz57qnKSB8Cnwg55ay5YqzIHwgMjUlICgxLTLnuqcpIDElICjiiaUz57qnKSB8Cnwg5LiZ5rCo6YW45rCo5Z+66L2s56e76YW25Y2H6auYIHwgMjQlICgxLTLnuqcpIDMlICjiiaUz57qnKSB8Cnwg5aSp5Yas5rCo6YW45rCo5Z+66L2s56e76YW25Y2H6auYIHwgMjElICgxLTLnuqcpIDUlICjiiaUz57qnKSB8CgrotYTmlpnmnaXmupDvvJrlhazlj7jlrpjnvZHvvIzljY7opb/or4HliLjnoJTnqbbmiYA=
收藏
行业数据
2025-06-30
原图定位
查看详情
图9奥雷巴替尼临床获益以及耐受性情况(续)
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
收藏
行业数据
2025-06-30
原图定位
查看详情
图11奥雷巴替尼在Ph+ALL适应症的临床疗效(续)
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
收藏
行业数据
2025-06-30
原图定位
查看详情
图7奥雷巴替尼(HQP1351)临床推进情况
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
收藏
行业数据
2025-06-30
原图定位
查看详情
英格兰15-99岁成人肿瘤患者分癌种五年生存率(%)
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
收藏
行业数据
2025-05-15
原图定位
查看详情
我国癌症5年生存率大幅改善,但仍低于发达国家
fCDlubTku70v5Zu95a62IHwgMjAwM+S4reWbvSB8IDIwMTXkuK3lm70gfCAyMDIy5Lit5Zu9IHwgMjAxNC0yMDE15pel5pysIHwgMjAxMi0yMDE4576O5Zu9IHwKfC0tLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfAp8IDXlubTnlJ/lrZjnjocgfCAzMC45JSAgICB8IDQwLjUlICAgIHwgNDMuNyUgICAgfCA2Ni4yJSAgICAgICAgfCA2OCUgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yM5Zu95rOw5ZCb5a6J6K+B5Yi456CU56m2
收藏
行业数据
2025-03-14
原图定位
查看详情
美国部分疾病5年癌症生存率自1970年以来明显提升
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
收藏
行业数据
2025-03-14
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
截至 2020 年 8 月 25 日,31 例血液学反应可评估受试者中,31 例(100%)获得完全血液学反应(CHR);41 例细胞遗传学可评估受试者中,31 例(75.6 %)获得主要细胞遗传学反应(MCyR),包括 28例(68.3%)完全细胞遗传学反应(CCyR)和 3例(7.3%)部分细胞遗传学反应(PCyR);41 例分子学反应可评估的受试者中,23 例(56.1%)获得主要分子学反应(MMR)。12 个月无进展生存(PFS)率为 85.7%,总体生存(OS)率为 100%。
行业数据
原图定位
当前图表所属:
亚盛医药-港股公司研究报告-小荷才露尖尖角细胞凋亡赛道大有可为-230507(36页).pdf
奥雷巴替尼销售额预测(亿元)
三代BCRABLTKI疗效及安全性对比
国内三代BCRABLTKI在研格局
我国BCRABLTKI竞争格局
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》